Viewing Study NCT00897234


Ignite Creation Date: 2025-12-25 @ 2:20 AM
Ignite Modification Date: 2025-12-27 @ 7:12 AM
Study NCT ID: NCT00897234
Status: COMPLETED
Last Update Posted: 2014-08-22
First Post: 2009-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Blood Samples From Patients With Non-Small Cell Lung Cancer and From Healthy Volunteers
Sponsor: University of Minnesota
Organization:

Study Overview

Official Title: Plasma Quantification of Cathepsin D and FAS in Non-Small Cell Lung Cancer
Status: COMPLETED
Status Verified Date: 2014-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: RATIONALE: Studying samples of blood from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer.

PURPOSE: This research study is looking at blood samples from patients with non-small cell lung cancer and from healthy volunteers.
Detailed Description: OBJECTIVES:

* Measure plasma cathepsin D levels in patients with non-small cell lung cancer and in healthy volunteers using mass spectometry.
* Measure fatty acid synthase levels in these patients and healthy volunteers using mass spectometry.

OUTLINE: Blood samples are collected from patients and healthy volunteers to measure the levels of cathepsin D and fatty acid synthase by proteomic profiling and mass spectrometry.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
0809M47482 OTHER IRB, University of Minnesota View